FlexISH ® NTRK1/NTRK3 DistinguISHTM Probe

The FlexISH ® NTRK1/NTRK3 DistinguISHTM Probe is designed to detect rearrangements affecting the chromosomal region 1q23.1 and 15q25.3 harboring the NTRK1 and NTRK3 gene region, respectively. The treatment of patients with NTRK fusion-positive cancers with a NTRK inhibitor is associated with high response rates, regardless of NTRK gene, fusion partner, and tumor type.


Probe Maps

 

Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
Z-2314-50
5 (50 µl)
CE IVD
Z-2314-200
20 (200 µl)
CE IVD
 

Download Information

 
 
 

1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

 
ISO 9001
ISO 13485
AEO
ZytoVision GmbH

LEGAL NOTICE

For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.


Accept & Continue